Press Releases | Medtronic

Month Year

Email alerts

Nov 13, 2014

Medtronic Study Reveals Significant Heart Rhythm Disorders Occurring in Patients Undergoing Hemodialysis

Data Presented at Kidney Week 2014 Find Irregular Heartbeats Occur Frequently Around Hemodialysis Sessions

MINNEAPOLIS and PHILADELPHIA - Nov. 13, 2014 - Medtronic, Inc. (NYSE: MDT) today revealed the results of a new study which found that atrial fibrillation (AF) and bradycardia-two common heart...
Nov 12, 2014

Medtronic Adds to Endurant 'AAA' Stent Graft System

New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic Aneurysms

MINNEAPOLIS -- Nov. 12, 2014 -- The global leader in medical technology for endovascular aortic repair (EVAR), Medtronic, Inc. (NYSE: MDT) today announced the launch in Europe and the United...
Nov 10, 2014

Medtronic Announces Japanese Approval and Launch of Implantable Cardioverter-Defibrillator System to Allow for Full-Body MRI Scans

Evera MRI(TM) ICD System Combines Proven Treatment Performance, Increased Longevity and Improved Comfort with Full-Body MRI Access

MINNEAPOLIS - Nov. 10, 2014 - Medtronic today announced Japanese regulatory approval and launch of the Evera MRI(TM) SureScan® implantable cardioverter-defibrillator (ICD) System for magnetic...
Nov 10, 2014

Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2015

MINNEAPOLIS - Nov 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the second quarter of its fiscal year 2015 on Tuesday, November 18, 2014. A news...
Nov 7, 2014

HeartWare Presentation At The Credit Suisse 2014 Healthcare Conference To Be Webcast

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
Nov 5, 2014

New Harvard Business Review Insight Center, Sponsored by Medtronic, Features Online Forum Focused on Innovating for Value in Healthcare

MINNEAPOLIS, Nov. 5, 2014 - Today marks the launch of a new Harvard Business Review (HBR) Insight Center, exclusively sponsored by Medtronic, which provides a forum for thought-leading commentary,...
Nov 5, 2014

Covidien Reports Fourth-Quarter and Fiscal 2014 Results

Fourth-quarter net sales up 7%; Medical Devices sales up 8%

DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 5, 2014-- Covidien plc (NYSE: COV) today announced financial results for the fourth quarter of fiscal 2014. Fourth-quarter net sales of $2.73 billion...
Nov 5, 2014

Covidien Announces Nine-Month Results of DURABILITY Iliac Study, Addition of Iliac Indication for EverFlex™ Stent System at VIVA 2014

EverFlex™ Self-Expanding Stent System Safe and Effective for the Treatment of Iliac Stenosis

LAS VEGAS--(BUSINESS WIRE)--Nov. 5, 2014-- Covidien plc (NYSE: COV) today announced nine-month results of the DURABILITY Iliac study and addition of the iliac indication for its EverFlex™ stent...
Nov 4, 2014

Medtronic of Canada Recognized as One of Canada's Top 100 Employers for 2015 - for the Fifth Year Running

Employee Engagement, Philanthropy Among Top Reasons for Selection

BRAMPTON, ONTARIO - November 4, 2014 - Medtronic of Canada Ltd., a trusted Canadian leader in innovative medical technologies and health system solutions, is pleased to have been recognized as one...
Nov 4, 2014

Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study

Consistent Outcomes Despite Common and Challenging Comorbidity Reinforce Overall Findings of IN.PACT SFA Trial

LAS VEGAS -- Nov. 4, 2014 -- For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug-coated balloon from Medtronic, Inc. (NYSE: MDT) provided a...
Nov 4, 2014

Covidien’s HawkOne™ Directional Atherectomy System Receives FDA 510(K) Clearance for the Treatment of Peripheral Arterial Disease

The HawkOne™ System strengthens Covidien’s directional atherectomy platform with a versatile solution for the treatment of peripheral arterial disease

DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 4, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) clearance for the HawkOne™ directional atherectomy system. The...
Nov 4, 2014

Covidien Announces 12-Month DEFINITIVE AR Results at VIVA 2014

Results suggest long-term benefits for peripheral artery disease patients treated with directional atherectomy followed by a drug-coated balloon

LAS VEGAS--(BUSINESS WIRE)--Nov. 4, 2014-- Covidien plc (NYSE: COV) today announced 12-month results of the DEFINITIVE AR study, the first randomized study designed to identify the clinical...
Nov 2, 2014

Spectranetics to Acquire Stellarex™ Drug Coated Balloon Assets From Covidien

Expands Spectranetics' portfolio of solutions to treat complex vascular conditions in projected $700 million drug coated balloon segment

COLORADO SPRINGS, Colo., and DUBLIN, Ireland, Nov. 2, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) and Covidien plc (NYSE:COV) today announced a definitive agreement under...
Oct 30, 2014

HeartWare International Reports $68.6 Million In Third Quarter 2014 Revenue; 25% Increase From Third Quarter 2013

- Record 675 HeartWare® Ventricular Assist Systems sold worldwide in Q3

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...
Oct 28, 2014

Covidien Launches First and Only Articulating Reloadable Absorbable Fixation Device for Minimally-Invasive Hernia Repair

ReliaTack™ device delivers superior access, stronger fixation and lower cost of care for minimally invasive hernia repair

DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 28, 2014-- Covidien plc (NYSE:COV) today announced the launch of ReliaTack™ articulating reloadable fixation device, the first and only of its kind for...
Oct 28, 2014

Medtronic Begins Global Clinical Study of Investigational Pericardial Surgical Aortic Heart Valve

MINNEAPOLIS - October 28, 2014 - Medtronic, Inc. (NYSE: MDT) today announced it has initiated the PERIGON (PERIcardial SurGical AOrtic Valve ReplacemeNt) Pivotal Trial, a global, prospective...
Oct 27, 2014

Covidien Launches Next-Generation SuperDimension™ Lung Navigation Software to Simplify Planning, Enhance Visualization During a Procedure

Covidien Launches Next-Generation SuperDimension™ Lung Navigation Software to Simplify Planning, Enhance Visualization During a Procedure

DUBLIN--(BUSINESS WIRE)--Oct. 27, 2014-- Further underscoring its ongoing commitment to lung health, Covidien (NYSE:COV) today unveiled a next-generation version of its superDimension™...
Oct 23, 2014

Covidien Joins Forces with the American Lung Association to Help Women Understand Their Increased Risk of Lung Cancer

Lung cancer is the number one cancer killer of women

DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 23, 2014-- Covidien (NYSE: COV) is joining forces with the American Lung Association’s LUNG FORCE movement to raise awareness of the threat that lung...
Oct 21, 2014

Medtronic Launches the Divergence(TM) Anterior Cervical Fusion System

System Offers New Approach to Single-Level ACDF Procedures

MEMPHIS, TENN. - October 21, 2014 - Medtronic, Inc. (NYSE: MDT) announced the U.S. launch of the DIVERGENCE(TM) Anterior Cervical Fusion System for the treatment of single-level cervical disc...
Oct 21, 2014

Many Underestimate Stroke, Would Miss Warning Signs Despite High Global Death Rate, Prevalence among Women

Covidien-World Stroke Organization Survey Shows Low Knowledge of Stroke Prevention, Treatment Options

Dublin, Ireland and Geneva – Oct. 22, 2014 – Despite its being the second leading cause of death worldwide, many people still do not recognize the threat stroke poses and the warning signs...
Oct 20, 2014

Medtronic Announces Global Launch of Titanium-Coated Peek Interbody Fusion Devices

MEMPHIS, TENN., - October 20, 2014 - Medtronic, Inc. (NYSE: MDT) introduced its Pure Titanium Coating (PTC) platform of interbody fusion devices for the spine today at the 2014 Congress of...
Oct 17, 2014

U.S. District Court Grants Covidien Preliminary Injunction against Ethicon’s Harmonic ACE®+7

DUBLIN, Ireland--(BUSINESS WIRE)--Oct. 17, 2014-- Covidien plc (NYSE: COV) today announced that the U.S. District Court for the District of Connecticut has granted a preliminary injunction against...
Oct 15, 2014

HeartWare Schedules Third Quarter Conference Call And Webcast

HeartWare International, Inc. (NASDAQ: HTWR) has scheduled a conference call to discuss its financial results for the three months ended September 30, 2014, at 8:00 a.m. U.S. Eastern Daylight Time...
Oct 14, 2014

Medtronic Begins Pivotal Study of First Predictive Low Glucose Management Technology for People with Diabetes

In-Clinic Study Marks Critical Step Toward an Artificial Pancreas and Key Milestone Toward U.S. Commercialization

MINNEAPOLIS - October 14, 2014 - Medtronic, Inc. (NYSE:MDT) today announced that the first patients have been enrolled in an investigational device exemption (IDE) study of its breakthrough...
Oct 13, 2014

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

Late-Breaking ADVANCE Direct Aortic Study Presented at EACTS Reaffirms CoreValve System's Positive Performance with Low Mortality and Stroke

MINNEAPOLIS and MILAN - Oct. 13, 2014 -Medtronic, Inc. (NYSE: MDT) today announced positive data from nine European centers in a study of the direct aortic approach (through the upper chest) with...

Show per page